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Abstract: The aim of this study was to investigate the in vivo toxicities of some novel 
synthetic chalcones. Chalcone and four chalcone analogues 1a–d were evaluated using 
zebrafish embryos following antibody staining to visualize their morphological changes 
and muscle fiber alignment. Results showed that embryos treated with 3'-hydroxychalcone 
(compound 1b) displayed a high percentage of muscle defects (96.6%), especially myofibril 
misalignment. Ultrastructural analysis revealed that compound 1b-treated embryos 
displayed many muscle defect phenotypes, including breakage and collapse of myofibrils, 
reduced cell numbers, and disorganized thick (myosin) and thin (actin) filaments. Taken 
together, our results provide in vivo evidence of the myotoxic effects of the synthesized 
chalcone analogues on developing zebrafish embryos. 
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1. Introduction 
Chalcone (1,3-diphenyl-2-propen-1-one), is an important compound for the biosynthesis of 
flavonoids. Chalcones have a general structure consisting of two phenyl groups, both with hydroxyl 
group, connected by a C3 bridge. Natural occurring chalcones, as well as synthetic chalcone analogues, 
have been demonstrated to possess many pharmaceutical effects including anti-inflammatory,  
anti-oxidant, anti-nociceptive, anti-parasites, and anti-proliferative activities [1–7]. Moreover,  
some chalcones can be conjugated or hybridized with other compounds and thus become potential 
anti-cancer therapeutic agents [8–10]. These observations highlight the importance and multiple 
applications of chalcones. However, current knowledge regarding the toxic effects of chalcones in 
vertebrates during embryogenesis is still limited. 
To date, many kinds of chalcones have been reported, including synthetic and natural ones. For 
their toxicity assessment, most previous studies used cancer cell lines [11–13], some used rat liver 
epithelial cells [14], and only few reports used rat (or dog) as a model to test the embryotoxicity and 
teratogenicity of some specific chalcones [15]. To exand our knowledge on chalcone toxicity 
(especially embryotoxicity), development of an alternative model is essential. The optical transparency 
and clear developmental stages of zebrafish (Danio rerio) embryos allows noninvasive and  
dynamic evaluation of embryotoxicity in vivo. In this study, we used embryonic zebrafish as a model 
to assess the toxic effects of chalcones (chalcone and some chalcone analogues) on muscle development 
in vivo. We generated a series of time- and dose-dependent chalcone exposure experiments. Subtle 
changes in the muscle fiber alignment can be easily observed by staining with specific monoclonal 
antibodies. This strategy is excellent for studying chalcone-induced myotoxicity during early 
embryonic development. 
2. Results and Discussion 
2.1. Chemistry 
For this study, we synthesized four chalcones 1a–d (Figure 1A). These aldol compounds were 
obtained using a procedure similar to one described previously [16–19]. Unfortunately, the reaction 
yields using this method was very low for the chalcones 1a and 1d (~15%). It is possible that 
intramolecular hydrogen bonding such as those observed in 1a or 1d prevents the aldol reaction. 
Therefore, O-isoproxylacetophenones 3a, 3b, and 3c were used as the starting material for our 
synthesis. The preparations of O-isoproxylacetophenones 3a–c were straightforward. Acetophenones 
2a–c were protected with isopropyl bromide and potassium carbonate in DMF in excellent yield. 
(89%, 91% and 90%, respectively). The isolated products 3a–c were then reacted with appropriate 
benzaldehydes and 5 N KOH to provide intermediates 4a–c and 6 in 85%, 81%, 90% and 87% yields. 
The O-isopropyl ether group was removed quantitatively with BCl3 to afford the target chalcones 1a, 
1b, 1c and 1d (Figure 1B). 
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Figure 1. (A) Structures of chalcone and compounds 1a–d; (B) Synthesis of compounds 1a–d. 
 
2.2. Titration and Survival Rates Analysis 
In order to access the toxic effects of chalcone and the synthetic chalcone analogues 1a–d on 
zebrafish larvae, first of all, we treated zebrafish embryos with low dosages of compounds (0.1, 0.5 
and 1 ppm) via exposure methods I–V (12–24, 12–36, 12–48, 12–60, 12–72 hpf; Figure 2A) to 
calculate the survival rates. As shown in Figure 2B–E, 99.2%–100% of the no treatment control 
(mock, 0 ppm) embryos and 96.4%–100% of chalcone and compounds 1a–d-treated embryos were 
alive after exposure via exposure protocols I–V. No significant differences in the survival rates were 
observed between no treatment control and low-dosage-treated groups (0.1, 0.5 and 1 ppm). Next, we 
treated zebrafish embryos with high dosages of chalcone and compounds 1a–d (3 and 5 ppm) via 
exposure methods I–V to calculate the survival rates. Results showed that the survival rates decreased 
as the time of exposure and the concentration (3 and 5 ppm) of chalcone and compounds 1a–d 
increased. At the end of the examination (72 h postfertilization, hpf), almost no embryos survived 
treatment with 5 ppm of chalcone and compounds 1a–d. On the other hand, we noticed that 3 ppm of 
compound 1b-exposed embryos (via method II: 12–36 hpf) displayed high survival rates (99.3%) and 
high percentage of malformed phenotypes (96.6%). Therefore, we used compound 1b-exposed 
embryos via exposure method II (12–36 hpf) as material for subsequent analysis. 
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Figure 2. (A) Exposure protocols used in this study; (B–E) Survival analysis of zebrafish 
embryos after chalcone, compounds 1a–d treatment. 
 
2.3. Phenotypic Changes after Chalcone Treatment 
To explore the toxicities of the chalcones (chalcone and the synthetic chalcone analogues 1a–d) 
during zebrafish embryogenesis, we exposed zebrafish embryos to different chalcones (3 ppm) via 
exposure methods II (12–36 hpf), and recorded their malformation phenotypes. Results showed that 
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embryos derived from the compounds 1a–d (3 ppm)-treated groups displayed shorter body length, 
curved trunks and malformed somite boundary than those with either no treatment control or the 
chalcone-treated group (Figure 3A vs. 3B–F). For further investigation, the monoclonal antibody F59 
was employed to visualize the alignments of muscle fibers in no treatment control and chalcones 
(including chalcone and compounds 1a–d)-treated zebrafish embryos. In both no treatment (mock) 
control and chalcone-treated embryos, muscle fibers aligned well in the chevron-shaped somatic  
hemi-segment (Figure 3A’,B’). In compounds 1a–d-treated embryos, muscle fibers were both split  
and short by 36 hpf, and lost their integrity and aligned disorderly (Figure 3C’–F’). These  
observations suggested that synthetic chalcone analogues (compounds 1a–d) are myotoxic and can 
impair myofibril alignment. 
Figure 3. Chalcones exposure affects myofibril alignment. (A–F) Visible and defective 
phenotypes of zebrafish embryos after chalcones treatment. Embryos were exposed to 
water (no treatment control; A) or water containing 3 ppm of chalcones (including 
chalcone and compounds 1a–d; (A’–F’) F59 monoclonal antibody staining of zebrafish 
embryo derived from each groups. All the photos were taken from the lateral view and 
were of developmental stages at 36 hpf. The exposure duration ranges from 12 to 36 hpf. 
 
2.4. Chalcones Affect Myofibril Ultrastructures and Alignment 
We have shown that chalcone-treated embryos have a shorter body length and curved trunk. Is it 
possible such malformations are due to the disorganization of myofibrils? To address this question, we 
carried out hematoxylin and eosin Y (H&E) staining and electron microscopy (EM) experiments. After 
H&E staining, boundaries of the segments of myofibrils in the embryos derived from the no treatment 
control group are compact with normal morphology (Figure 4A). In contrast, myofibrils’ organization 
are fractured in the compound 1b-treated embryos (Figure 4B). Ultrastructural analysis indicated that 
in compound 1b-treated embryos many myofibrils are broken and collapsed. The numbers of 
myofibrils is greatly decreased. The remainder are thinner and with fragmentary cytosolic  
components. Although the Z-line is still visible, the thick (myosin) and thin (actin) filaments are 
disorganized (Figure 5A vs. 5B). Notably, cytosolic electron density in the compound 1b-treated 
embryos is more greatly decreased than in the no treatment control group (Figure 5B vs. 5A). 
However, mitochondria electron density in the compound 1b-treated embryos is increased, indicating 
that some substances are being produced or accumulated in the mitochondria. Taken together, we 
concluded that compound 1b affects myofibril alignment and organization. 
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Figure 4. Compound 1b affects myofibril alignment. Representative images of 
hemetoxylin (H) & eosin Y (E) staining of zebrafish embryo after exposure to water (A) or 
water containing 3 ppm of compound 1b. (B) Dashed lines mark the boundary of somites. 
 
Figure 5. Compound 1b affects ultrastructure of myofibril. Representative images of TEM 
of zebrafish embryo after exposure to water (A) or water containing 3 ppm of compound 1b. 
(B) Arrows indicate the positions of Z-line. M: mitochondria; N: nucleus. 
 
3. Experimental 
3.1. General Information 
Proton (300 MHz) and carbon (75 MHz) NMR spectra were recorded on a Varian Mercury-300 
NMR spectrometer (Agilent, Santa Clara, CA, USA). Cchemical shifts are reported on the δ scale as 
parts per million (ppm) downfield from tetramethylsilane (TMS) used as internal reference. Mass 
spectra were measured with a VG Analytical Model 70–250 s Mass Spectrometer (Varian, Palo Alto, 
CA, USA). All reagents were used as obtained commercially. 
3.2. Synthesis of Chalcone Analogues 
A mixture of the corresponding acetophenone 2a–c (1 equiv), isopropyl bromide (1.1 equiv), and 
potassium carbonate (1.1 equiv) in DMF (0.3 M) was stirred at 70 °C for 3 h. Then, the reaction 
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mixture was added to water and extracted with CH2Cl2. The purified O-isopropyl product 3a–c was 
obtained in excellent yield by column chromatography (silicagel, 70–230 mesh) using CH2Cl2 as 
eluent. The isolated product 3a–c (1 equiv) was then reacted with the appropriate benzaldehyde  
(1 equiv) and 5N KOH at room temperature until the aldehyde was consumed. After that, HCl (10%) 
was added until neutrality. In the cases where the chalcones precipitated, they were filtered and 
crystallized from MeOH. In the other cases, the product was purified using column chromatography with 
EtOAc/hexane as eluent. The O-isopropyl ether groups of 4a–c, 6 (1 equiv) were removed quantitatively 
with BCl3 (1.1 equiv) in CH2Cl2 (0.3 M) at 0 °C for 2 h to afford the target chalcones 1a–d. 
1-(2-Hydroxyphenyl)-3-phenylpropenone (1a). Mp 89–90 (lit. 89 °C) [20]; 1H-NMR (CDCl3): 12.80 
(1H, s, -OH), 7.93 (1H, d, J = 15.6 Hz), 7.93 (1H, d, J = 8.0 Hz), 7.66 (1H, d, J = 15.6 Hz),  
7.68–7.65 (1H, m), 7.55–7.42 (5H, m), 7.03 (1H, dd, J = 8.0 Hz, 1.0 Hz), 6.95 (1H, td, J = 7.2 Hz, 1.0 Hz); 
13C-NMR (CDCl3): 193.8, 163.5, 145.4, 136.4, 134.5, 130.9, 129.6, 129.0, 128.6, 120.0, 119.9, 118.8, 
118.6; EI-MS m/z (rel.int.%): 224 [M+,15], 175 (18), 131 (18), 119 (100), 91 (94), 77 (28), 65 (33). 
1-(3-Hydroxyphenyl)-3-phenylpropenone (1b). Mp 120–121 °C (lit. 120.2–120.6 °C) [17]; 1H-NMR 
(CDCl3): 7.83 (1H, d, J = 15.6 Hz), 7.66–7.58 (3H, m), 7.51 (1H, d, J = 15.6 Hz), 7.45–7.34 (5H, m), 
7.14 (1H, ddd, J = 8.0 Hz, 2.4 Hz, 1.2 Hz), 4.8–4.2 (1H, br s, -OH); 13C-NMR (CDCl3):190.9, 156.5, 
145.5, 139.4, 134.7, 130.7, 129.9, 129.0, 128.6, 121.9, 120.9, 120.5, 115.2; EI-MS m/z (rel.int.%): 224 
[M+,100], 223 (79), 195 (14), 121 (40), 103 (20), 93 (19), 65 (19). 
1-(4-Hydroxyphenyl)-3-phenylpropenone (1c). Mp 179–180 °C (lit. 175–179 °C) [19]; 1H-NMR 
(CDCl3): 8.00 (2H, d, J = 8.8 Hz), 7.80 (1H, d, J = 15.6 Hz), 7.63 (2H, dd, J = 2.6 Hz, 2.0 Hz), 7.53 (1H, d, 
J = 15.6 Hz), 7.42–7.40 (3H, m), 6.93 (2H, d, J = 8.8 Hz), 2.10–1.90 (1H, br s, -OH); 13C-NMR 
(CDCl3):188.4, 162.9, 143.8, 136.4, 132.0, 131.2, 131.0, 129.8, 129.4, 123.0, 116.2; EI-MS m/z 
(rel.int.%): 224 [M+,100], 223 (79), 103 (15), 65 (20). 
1-(2-Hydroxyphenyl)-3-(3-hydroxyphenyl)propenone (1d). Mp 180–181 °C (lit. 180–181 °C) [21];  
1H-NMR (acetone-d6): 12.87 (1H, br s, -OH), 8.60 (1H, br s, -OH), 8.26 (1H, dd, J = 8.4 Hz, 1.6 Hz), 
7.98 (1H, d, J = 15.6 Hz), 7.85 (1H, d, J = 15.6 Hz), 7.56 (1H, ddd, J = 8.6 Hz, 8.6 Hz, 1.6 Hz),  
7.38–7.25 (3H, m), 7.03–6.94 (3H, m); 13C-NMR (acetone-d6):195.0, 164.5, 158.7, 146.3, 137.4, 
137.1, 131.3, 130.9, 121.4, 121.3, 120.8, 119.8, 119.0, 118.9, 116.2; EI-MS m/z (rel.int.%):  
240 [M+,100], 239 (79), 191 (15), 147 (18), 107 (81), 65 (33). 
3.3. Fish Care and Chemicals Treatment 
Mature zebrafish (AB strain) was supplied by the Zebrafish Core at Academia Sinica  
(ZCAS, Taipei, Taiwan). Embryos were produced using standard procedures [22–24] and were staged 
according to standard criteria: hours postfertilization, hpf; or days postfertilization (dpf) [25]. 
3.4. Histology, Antibody Labeling and Images 
The procedures for H&E staining, antibody labeling and cryosection have been described 
previously [26–29], except that F59 (Hybridoma Bank, Iowa City, IA, USA) was used as primary 
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antibody. The procedures of embedding and cryosectioning described by Chen and Tsai [30] were 
followed, except that embryos developed at 36 hpf were used and sections of 10 μm were obtained.  
All embryos were observed under a microscope (DM 2500, Leica, Wetzlar, Germany) equipped with 
Nomarski differential interference contrast optics and a fluorescent module having GFP and  
DsRed filter cubes (Leica). Images of embryos were captured at specific stages with a digital carema 
(Sony, Tokyo, Japan), or were examined by a Leica SP2 confocal microscope. 
3.5. Electron Microscopy 
The zebrafish embryos after exposure to water or water containing compound 1b were fixed with 
2% paraformaldehyde and 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.2) overnight at 4 °C. 
Subsequently, the embryos were washed in buffer twice for 15 min each and then postfixed using  
1% osmium tetroxide in 0.1 M cacodylate buffer for 1 h at room temperature. Samples were 
dehydrated in an ethanol series and embedded in resin using standard procedures. Ultrathin sections 
were cut and double-stained with uranyl acetate and lead citrate, and then examined in a Hitachi H-600 
electron microscope (Hitachi, Tokyo, Japan). 
4. Conclusions 
This study provide a myotoxic assessment of chalcone and some synthetic chalcone analogues in a 
zebrafish model. This toxicity information should prove useful for further structure-activity 
relationship analysis. 
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